Two novel prevalent polymorphisms in the hormone-sensitive lipase gene have no effect on insulin sensitivity of lipolysis and glucose disposal.
Free fatty acids released during triglyceride lipolysis play an important role in obesity-associated insulin resistance of glucose disposal. Individual sensitivity of lipolysis to the suppressive effect of insulin varies greatly among healthy subjects. It is possible that genetic factors contribute to this variation. Among the many proteins involved in the regulation of lipolysis, hormone-sensitive lipase (HSL) represents a prime candidate for genetic variants contributing to the biological variation of insulin sensitivity of lipolysis. We determined the insulin sensitivity of lipolysis (suppression of isotopically [primed-continuous infusion of d5 glycerol] measured glycerol rate of appearance) and of glucose disposal, using a three-step (n = 20) or standard (n = 53) hyperinsulinemic euglycemic clamp in 73 healthy, unrelated subjects. To assess the possible role of genetic polymorphisms, we directly sequenced the coding region of the HSL gene and the noncoding exon B from these subjects. We identified two silent mutations and three amino acid polymorphisms: Arg262Met (prevalence, 5%), Glu620Asp (prevalence, 31%) and Ser681Ile (prevalence, 22%). The latter two are located in the regulatory domain of HSL but neither had a significant impact on insulin sensitivity of lipolysis or glucose disposal (with and without adjustment for obesity and age as covariates; all P values > 0.20). We conclude that a number of genetic polymorphisms in HSL exist, some of which are highly prevalent. Neither of the polymorphisms we identified in the coding region, however, contributed measurably to the biological variation of insulin sensitivity in our lean, healthy population.
Stumvoll
M
M
Department of Endocrinology and Metabolism, Eberhard-Karls-Universität, D-72076 Tübingen, Germany. michael.stumvoll@med.uni-tuebingen.de
Wahl
H G
HG
Jacob
S
S
Rettig
A
A
Machicao
F
F
Häring
H
H
D000328:Adult; D000483:Alleles; D001224:Aspartic Acid / Q000235:genetics; D001786:Blood Glucose / Q000378:metabolism*; D005091:Exons; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D015309:Glucose Clamp Technique; D018698:Glutamic Acid / Q000235:genetics; D005990:Glycerol / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D007333:Insulin Resistance; D007532:Isoleucine / Q000235:genetics; D007700:Kinetics; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D009154:Mutation; D009765:Obesity / Q000150:complications; D011110:Polymorphism, Genetic; D012045:Regulatory Sequences, Nucleic Acid; D017422:Sequence Analysis, DNA; D012694:Serine / Q000235:genetics; D002787:Sterol Esterase / Q000235:genetics*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D007532:Isoleucine; D001224:Aspartic Acid; D018698:Glutamic Acid; D012694:Serine; D002787:Sterol Esterase; D005990:Glycerol